There is a newer version of the record available.

Published June 13, 2019 | Version 1
Dataset Open

Human TMEM16K (ANO10); A Target Enabling Package

  • 1. Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford
  • 2. Department of Chemistry, Weill Cornell Medical School, New York USA
  • 3. Department of Pharmacology, University of Oxford
  • 4. Department of Biochemistry, University of Oxford
  • 5. Nuffield Department of Rheumatology, Orthopaedics and Musculoskeletal Sciences, Unviersity of Oxford
  • 6. Department of Biochemistry, University of Oxford; Structural Genomics Consortium, Nuffield Department of Medicine, University of Oxford
  • 7. Albert Einstein College of Medicine, Department of Biochemistry, Bronx NY
  • 8. Oxford Particle Imaging Centre, Division of Structural Biology, Wellcome Trust Centre for Human Genetics, University of Oxford
  • 9. Department of Biochemistry, Weill Cornell Medical School, New York USA; Department of Anesthesiology, Weill Cornell Medical School, New York USA; Department of Physiology and Biophysics, Weill Cornell Medical School, New York USA

Description

There are ten members of the TMEM16/Anoctamin family of proteins in mammals. Although the first members of this family to be discovered, TMEM16A and TMEM16B, have a calcium-regulated chloride channel function, subsequently other members of the family, such as TMEM16F, were found to have lipid scramblase activity combined with non-selective ion channel activity. TMEM16K was a relatively understudied member of the family despite the observation that mutations in TMEM16K have been linked to the genetic disease autosomal recessive spinocerebellar ataxia Type 10 (Also known as SCAR10 or ARCA3). SCAR10 is a late-onset neurodegenerative disorder which causes marked atrophy of the cerebellum with consequential deterioration in limb co-ordination, speech and eye movement. We have solved several structures of human TMEM16K through X-ray crystallography and cryo-EM capturing both active and inactive conformational states. Through collaborations, we have investigated TMEM16K’s function and location in cells. We were able to show that TMEM16K acts as a lipid scramblase with non-selective ion channel activity that is sensitive to both Ca2+ and lipid chain lengths. We also showed that TMEM16K mainly resides in the endoplasmic reticulum where it may be regulated by the ER’s unique lipid profile. Our highest resolution cryo-EM structure for TMEM16K allowed us to identify a bound lipid in the cavity behind the groove that transports the lipid headgroups and this lipid binding site may represent an allosteric modulator site, providing a direction for the design of binders which could modulate TMEM16K activity in cells.

Notes

This document represents version 1 of the TEP datasheet and includes all updates on the project as of June 2019. For more information about TEPs and the TEP Programme, please visit https://thesgc.org/tep

Files

TMEM16K_TEP_datasheet_v1.pdf

Files (2.1 MB)

Name Size Download all
md5:73969a470ad6738a92aff57587df7220
2.1 MB Preview Download

Additional details

Related works

Funding

A UK Hub to Catalyse Open Target Discovery. 106169
Wellcome Trust